Literature DB >> 17300864

Aldose reductase regulates TNF-alpha-induced PGE2 production in human colon cancer cells.

Ravinder Tammali1, Kota V Ramana, Satish K Srivastava.   

Abstract

Pro-inflammatory cytokines such as TNF-alpha play an important role in the pathophysiology of diseases such as Crohn's and ulcerative colitis which cause increased risk of colorectal cancer. However, the mechanisms underlying colon carcinogenesis are not well understood. Herein we report that inhibition/antisense abolition of polyol pathway enzyme, aldose reductase (AR) inhibited the TNF-alpha-induced synthesis of prostaglandin E2 and the activity of cyclooxygenase (Cox) in human colon cancer cells, Caco-2. Inhibition of AR prevented TNF-alpha-induced activation of PKC and NF-kappaB which resulted in the abrogation of Cox-2 mRNA and protein expression. These results suggest that inhibition of AR could be a novel chemopreventive approach to colon cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17300864      PMCID: PMC1945127          DOI: 10.1016/j.canlet.2007.01.001

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  31 in total

Review 1.  The gut's role in metabolism, mucosal barrier function, and gut immunology.

Authors:  R C DeWitt; K A Kudsk
Journal:  Infect Dis Clin North Am       Date:  1999-06       Impact factor: 5.982

2.  C/EBP{beta} and its binding element are required for NF{kappa}B-induced COX2 expression following hypertonic stress.

Authors:  Jing Chen; Min Zhao; Reena Rao; Hiroyasu Inoue; Chuan-Ming Hao
Journal:  J Biol Chem       Date:  2005-02-14       Impact factor: 5.157

3.  Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells.

Authors:  Ravinder Tammali; Kota V Ramana; Sharad S Singhal; Sanjay Awasthi; Satish K Srivastava
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

4.  Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice.

Authors:  I Kawamura; E Lacey; N Yamamoto; F Sakai; S Takeshita; M Inami; F Nishigaki; Y Naoe; S Tsujimoto; T Manda; K Shimomura; T Goto
Journal:  Anticancer Res       Date:  1999 Sep-Oct       Impact factor: 2.480

5.  Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKI.

Authors:  I Kawamura; E Lacey; M Inami; F Nishigaki; Y Naoe; S Tsujimoto; T Manda; T Goto
Journal:  Anticancer Res       Date:  1999 Sep-Oct       Impact factor: 2.480

6.  Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth.

Authors:  Kota V Ramana; Aruni Bhatnagar; Sanjay Srivastava; Umesh C Yadav; Sanjay Awasthi; Yogesh C Awasthi; Satish K Srivastava
Journal:  J Biol Chem       Date:  2006-04-28       Impact factor: 5.157

7.  Endotoxin triggers nuclear factor-kappaB-dependent up-regulation of multiple proinflammatory genes in the diaphragm.

Authors:  Alexandre Demoule; Maziar Divangahi; Linda Yahiaoui; Gawiyou Danialou; Dusanka Gvozdic; Katherine Labbe; Weisheng Bao; Basil J Petrof
Journal:  Am J Respir Crit Care Med       Date:  2006-06-15       Impact factor: 21.405

8.  Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice.

Authors:  M Suganuma; S Okabe; M W Marino; A Sakai; E Sueoka; H Fujiki
Journal:  Cancer Res       Date:  1999-09-15       Impact factor: 12.701

9.  Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats.

Authors:  D S Han; F Li; L Holt; K Connolly; M Hubert; R Miceli; Z Okoye; G Santiago; K Windle; E Wong; R B Sartor
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-11       Impact factor: 4.052

10.  Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages.

Authors:  Kota V Ramana; Amin A Fadl; Ravinder Tammali; Aramati B M Reddy; Ashok K Chopra; Satish K Srivastava
Journal:  J Biol Chem       Date:  2006-09-06       Impact factor: 5.157

View more
  26 in total

1.  Comparative proteomics analysis of serum proteins in ulcerative colitis patients.

Authors:  Nan Li; Xueming Wang; Yuefan Zhang; Junshan Zhai; Tuo Zhang; Kaihua Wei
Journal:  Mol Biol Rep       Date:  2011-12-24       Impact factor: 2.316

Review 2.  The role of antioxidants and pro-oxidants in colon cancer.

Authors:  William L Stone; Koyamangalath Krishnan; Sharon E Campbell; Victoria E Palau
Journal:  World J Gastrointest Oncol       Date:  2014-03-15

3.  Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells.

Authors:  Ravinder Tammali; Ashish Saxena; Satish K Srivastava; Kota V Ramana
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

Review 4.  Targeting aldose reductase for the treatment of cancer.

Authors:  Ravinder Tammali; Satish K Srivastava; Kota V Ramana
Journal:  Curr Cancer Drug Targets       Date:  2011-06       Impact factor: 3.428

5.  Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells.

Authors:  Kota V Ramana; Ravinder Tammali; Satish K Srivastava
Journal:  Mol Cancer Ther       Date:  2010-03-30       Impact factor: 6.261

6.  Inhibition of aldose reductase prevents colon cancer metastasis.

Authors:  Ravinder Tammali; Aramati B M Reddy; Ashish Saxena; Piotr G Rychahou; B Mark Evers; Suimin Qiu; Sanjay Awasthi; Kota V Ramana; Satish K Srivastava
Journal:  Carcinogenesis       Date:  2011-06-03       Impact factor: 4.944

7.  Aldose reductase deficiency protects from autoimmune- and endotoxin-induced uveitis in mice.

Authors:  Umesh C S Yadav; Mohammed Shoeb; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-17       Impact factor: 4.799

Review 8.  Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.

Authors:  Satish K Srivastava; Umesh C S Yadav; Aramati B M Reddy; Ashish Saxena; Ravinder Tammali; Mohammad Shoeb; Naseem H Ansari; Aruni Bhatnagar; Mark J Petrash; Sanjay Srivastava; Kota V Ramana
Journal:  Chem Biol Interact       Date:  2011-02-24       Impact factor: 5.192

Review 9.  Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Authors:  Daniela Salvemini; Sangwon F Kim; Vincenzo Mollace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

10.  Tumor necrosis factor (TNF)-alpha persistently activates nuclear factor-kappaB signaling through the type 2 TNF receptor in chromaffin cells: implications for long-term regulation of neuropeptide gene expression in inflammation.

Authors:  Djida Ait-Ali; Valérie Turquier; Yannick Tanguy; Erwan Thouënnon; Hafida Ghzili; Lourdes Mounien; Céline Derambure; Sylvie Jégou; Jean-Philippe Salier; Hubert Vaudry; Lee E Eiden; Youssef Anouar
Journal:  Endocrinology       Date:  2008-02-21       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.